1. Streptozotocin was used to induce diabetes in two inbred strains of rats, Lewis and DA, known to have different glomerular properties.
INTRODUCTION
One of the most intriguing features of diabetic nephropathy (DN) is that it affects only 45% of diabetic subjects. Even after long-term follow up there remains a group of diabetic subjects who maintain normal renal function and never develop proteinuria [l] . There has been a marked increase in the incidence of type I diabetes [2-51, but the proportion who develop DN may be falling [6, 71 . It is not known what predisposes an individual diabetic subject to the development of DN. Certainly, there is an association between poor glycaemic control and a greater risk of developing proteinuria [6] , but, conversely, improved glycaemic control using continuous subcutaneous insulin infusion has failed to prevent deterioration in renal function, even when started as early as the stage of intermittent clinical proteinuria 181. An inherited predisposition to DN has been proposed [9] and it is possible that inherited differences in glomerular properties might explain the variations in susceptibility.
Lewis rats have a lower charge on their glomerular polyanion and a lower mesangial uptake of circulating macromolecules than do DA rats [lo] , and in theory both these properties might influence the development of DN. In order to examine this hypothesis, the progression of DN in streptozotocin-diabetic Lewis and DA rats has been studied.
METHODS
Healthy male Lewis and DA rats weighing 125-175 g were used. The animals were placed in metabolic cages and, after a 24 h equilibration period, two 24 h urine collections were obtained for baseline measurements of proteinuria. Blood samples were then taken from the tail veins for baseline measurement of plasma glucose. Diabetes was induced by an intravenous injection of streptozotocin in a dose of 80 mg/kg body weight, mixed in a citrate buffer. After 3 days a further blood sample was taken to confirm the development of hyperglycaemia. Those animals whose plasma glucose remained below 15 mmol/l received a second injection of streptozotocin in a dose of 40 mg/kg body weight. If, after a further 3 days, the plasma glucose remained below 15 mmol/l, they were then excluded from the study. None of the rats was treated with insulin. Control animals underwent the same procedures but received an injection of citrate buffer only. Tail vein blood samples were taken at monthly intervals to monitor plasma glucose levels. All animals were fed on standard rat chow and had free access to water. After 1,2, 3 , 4 , and 6 months of diabetes, two 24 h urine collections were obtained for measurement of proteinuria.
Assessment of dietary protein intake was made by calculating the amount of powdered rat chow (comprising 22.7% protein) taken by rats in the metabolic cages before injection, and taken by control and. diabetic rats after 6 months. Urinary total protein was determined by the Coomassie Blue technique [ 1 11.
Four groups of rats were used as indicated in Table 1 . Half of the rats in group 2 were killed at 1 month for preliminary mesangial uptake experiments. The remainder of group 2 were used for longer term experiments (measurement. of proteinuria for up to 1 year). All the animals in group 4 were killed at 3 months after experiments to measure the glomerular filtration rate (GFR), effective renal plasma flow (ERPF) and systemic arterial blood pressure (the methods and results of which are described elsewhere). After 6 months, the surviving diabetic rats from groups 1 and 3 (eight Lewis and nine DA rats) were returned to the metabolic cages, and two 24 h urine collections were made. These rats were used in GFR/ERPF/blood pressure experiments, as noted above. One Lewis rat and one DA rat died after the urine collection procedures, but before they could be used in the final experiments. At the end of these experiments the animals were killed and their kidneys were removed. One was divided and fixed in buffered formalin, and the other was cut into 1 mm cubes and fiied in glutaraldehyde. Sections were stained with periodic acid/Schiff for examination under light microscopy. Twenty glomeruli were selected at random from each section and the number of insudative lesions in these glomeruli were recorded. The term insudative lesion embraces capsular drops and fibrin caps, which are similar lesions occurring in different sites within the glomerulus. They appear as localized accumulations of intensely eosinophilic material, and are probably the result of insudation of plasma constituents, including lipids, proteins and mucopolysaccharides, into capillary or arteriolar walls [ 121. After imbedding in plastic, serial sections were cut from the glutaraldehyde-fixed specimens until the mid-section of the glomerulus was reached. Low-power photographs were then taken ( x 5400) from one glomerulus from each animal for measurement of mesangial area. From these photographs, the areas of the glomerular tuft and the areas of the mesangium were measured using a planimeter (Digiplan, Kontron Messgerate, Eching, Germany), and these results were expressed as a ratio. In defining the mesangial areas, the borders with the capillary loop were taken to be the endothelial cells, and those with the urinary space to be the epithelial cells. Where the epithelial and endothelial surfaces of the glomerular basement membrane (GBM) ran parallel, the basement membrane was taken to be capillary basement membrane, and beyond that, basement membrane within the mesangial area. The glomerular tuft was defined as that area enclosed by the epithelial cells of the GBM, and includes the mesangial regions and the lumina of the capillary loops.
High-power ( x 26 000) photographs were taken at random for measurement of GBM thickness by the orthogonal intercept method [ 131. At least 140 measurements were taken from each animal, and from these measurements the harmonic mean GBM thickness (MGBMT ) was calculated. All the histological examinations were performed blind.
The Student's f-test and the Mann-Whitney U-test were used for statistical analyses.
RESULTS

Plasma glucose
Plasma glucose rose after injection of streptozotocin from mean values of 6.1 mmol/l (SD 0.9 mmol/l; n = 48) and 7.1 mmol/l (SD 0.9 mmol/l; n = 45) in Lewis and DA rats, respectively to 26.6 mmol/l (SD 10.3 mmol/l; n = 20) and 24.9 mrnol/l (SD 8.5 mmol/l; n = 27) after 1 month of diabetes. The levels varied thereafter, but remained above 24 mmol/l in all diabetic animals for the 6 months of the experiment. Using the Student's f-test, no significant interstrain differences were found in diabetic rats (see Fig. 1 ).
Diet and weight
Diabetic animals of both strains had a significantly increased appetite in comparison with the control animals (see Table 2 ), but there were no inter-strain differences (Student's r-test).
The effects of diabetes on animals' weight is shown in Table 2 . There were no inter-strain differences in weight in the rats before injection with streptozotocin. The healthy control Lewis rats grew to a greater weight than did the DA control rats after 6 months of the experiment, which accounts for their higher food consumption. Diabetic animals did not lose weight, but failed to gain weight at the same rate as the control animals.
Dietary protein intake
There was a gcneral increase in dietary protein intake in all diabetic animals, but again the Student's r-test revealed no sigmficant inter-strain differences (see Fig. 2 ).
Proteinuria
The results from assay of urinary protein were nonparametric and were therefore logarithmically transformed. Comparisons were then made on the log-transformed data using the Student's f-test. F'roteinuria increased in both strains after the induction of diabetes. In the DA rats the level of proteinuria remained fairly constant thereafter, but in the Lewis rats there was a progressive increase in proteinuria so that after 3 months Before injection 6 month control 6 month diabetic rats rats Fig. 2 . Dietary protein intake in healthy control and diabetic Lewis ( a ) and DA (0) rats before injection of streptozotocin and after 6 months of the experiment. The number of animals involved are indicated at the base of each column, and error bars refer to SDS. There were no significant inter-strain differences between diabetic animals (Student's t-test). Abbreviation: NS, not significant.
of diabetes the difference between the strains was significant ( P < 0.05). The inter-strain difference increased further thereafter (see Fig. 3 ).
Proteinuria in control rats
The levels of proteinuria in control rats are shown in Table 3 . There was a significant increase in proteinuria in both strains after 1 month of the experiment (P<0.0001, Student's t-test). The increase was greater in Lewis than in DA rats, but thereafter there were no further significant increases in proteinuria in either strain.
Histology
The major finding on light microscopy was the presence of insudative lesions in the kidneys of the diabetic rats. There were significantly more such lesions in the diabetic Lewis rats (P=0.01, Mann-Whitney Utest, see Fig. 4 ). No insudative lesions were found in two control rats of each strain after 6 months of the experiment. In the controls that were examined after 12 months, one lesion was found in the kidneys of three DA rats, and six lesions in those of three Lewis rats. There were increases in the ratio of the mesangial areas to the glomerular tuft areas in the diabetic animals of both strains as compared with controls. The results, expressed as the mesangial area as a percentage of the glomerular tuft area, were 44.8% (median) in diabetic Lewis rats and 18.0% in Lewis controls ( P < 0.01, Mann-Whitney Utest). The corresponding values for the DA rats were 31.4% in diabetic and 23.1% in control animals ( P < 0.05). The inter-strain differences in the diabetic animals were significant (PC0.05; see Fig. 5 ) . The differ- 10.
ence in the degree of mesangial expansion in the two strains is illustrated in Fig. 6 . The harmonic MGBMT increased with age in control rats of both strains from (mean values) 173.86 nm (SD 15.6 nm; n = 2) at 6 months after the start of the experiment to 208.78 nm (SD 15.0; n = 3) at 12 months for DA rats, and from 171.32 nm (SD 4.1; n = 2 ) at 6 months to 226.58 nm (SD 20.5; n = 3) at 12 months for Lewis rats. Age-matched controls were therefore used for purposes of comparison. The harmonic MGBMT was virtually the same in diabetic DA rats 6 months after injection as in age-matched controls [174.26 nm (SD 24.8 nm; n = 8 ) versus 173.86 nm (SD 15.6 nm; n = 2)]. In Lewis rats the 6 month diabetic animals showed an increase compared with controls [182.63 nm (SD 36.7 nm; n = 7 ) versus 171.32 nm (SD 4.1 nm; n = 2)], but this was not significant. The inter-strain differences between diabetic animals were not significant.
Proteinuria and plasma glucose in rats used for histology
In the subset of rats used for histological studies, proteinuria was heavier in the Lewis rats (mean 100.9 mg/ 24 h; SD 146.24 mg/24 h; n = 7; median 25.04 mg/24 h) than in the DA rats (mean 10.19 mg/24 h; SD 2.11 mg/ 24 h; n = 8; median 9.89 mg/24 h) (P<O.O5, MannWhitney U-test). There were no significant differences in plasma glucose between these two groups. Mean plasma glucose in the Lewis rats was 33.45 mmol/l (SD 5.55 mmol/l; n = 7) and in the DA rats was 26.45 mmol/l (SD 6.14 mmol/l; n = 8) ( P = 0.08, Mann-Whitney U-test).
DISCUSSION
The development of DN follows a clearly defined pattern. Initially the GFR and ERPF are elevated and there is an increase in kidney size. Abnormalities in protein excretion begin at an early stage and are progressive. Hypertension and a progressive decline in renal function follow, leading ultimately to end-stage renal failure. Morphological changes on light microscopy are present in virtually all type I diabetic subjects 10 years after diagnosis [14] . In advanced diabetic renal disease, classical nodular intercapillary sclerosis (the Kimmelstiel-Wilson lesion), diffuse intercapillary sclerosis, fibrin caps and capsular Fig. 6 . Low-power electron micrographs (original magnification x 5400) of the mesangial areas of ( a ) a Lewis rat and ( b ) a DA rat, both after 6 months of diabetes. The former shows considerably greater mesangial expansion. drops are found. The ultrastructural changes found in DN are progressive thickening of the GBM, first detectable If years after the onset of diabetes [ 151, and an expansion of the mesangial matrix which increases with increasing duration of diabetes [ 16) .
Injection of streptozotocin and alloxan are the most popular methods for the induction of diabetes. Streptozotocin is more specific in its effects, less likely to cause ketosis and less prone to inter-animal variation in terms of effective dose [ 171. Although streptozotocin is nephrotoxic in man, it has been clearly demonstrated that it is not nephrotoxic in the rat [18, 191 . The streptozotocindiabetic rat is regarded as a useful model of insulindependent diabetes mellitus, since the alterations in function and the pathological changes found in this model are similar to those found in human diabetes. Both develop glomerular hypertrophy, GBM thickening and mesangial expansion, but the rat does not develop classical Kimmelstiel-Wilson nodular lesions. Functionally, both develop an increase in GFR and proteinuria. However, perhaps because of the shorter time course of their diabetes, the laboratory rats do not develop renal failure. Hirose et al. [20] noted that it was many months before greater GBM thickening in diabetic Lewis rats compared with control animals was apparent. This explains the lack of GBM thickening in our 6 month experiment as our controls were age-matched. To detect differences in GBM thickening between the two strains of rat, a considerably longer experiment would be necessary.
Genetic differences in the susceptibility to DN have been proposed as a possible explanation for the fact that only 45% of type I diabetic subjects develop the condition. Viberti et a[. 1211 have suggested that a familial tendency to hypertension may be the predisposing factor. They found that arterial blood pressure was significantly higher in the parents of proteinuric insulin-dependent diabetic subjects compared with parents of non-proteinuric patients [21] . They also demonstrated that an elevated sodium-lithium countertransport activity in erythrocytes (a marker of predisposition to hypertension) in certain insulin-dependent diabetic subjects was linked to an increased risk of development of DN. Their findings were confirmed by Mangili et al. [22] and Krolewski et al. [23] . The glomeruli of Lewis rats differ from those of DA rats in that they have a lower negative charge on the glomerular polyanion and a lower mesangial uptake of circulating macromolecules [lo] . Both these properties may influence the development of DN. The fixed negative charge on the glomerular capillary wall normally retards the filtration of negatively charged molecules such as albumin. Loss of this charge leads to proteinuria and to clogging of the filtration surface by larger negatively charged molecules [24] , which may lead to an increase in the pressure in the glomerular capillaries. A reduction in the GBM sialic acid (which makes up a significant part of the fived negative charge of the GBM) is a well recognized and consistent biochemical feature of diabetes (25-281. The content of heparan sulphate, the major glycosaminoglycan of the GBM in rats and man, is also reduced in streptozotocin-diabetic rats (291. Diabetes causes structural and secondary functional changes in the mesangium, so that its capacity to clear macromolecules is impaired in the most thickened areas [30] . A high mesangial uptake of circulating macromolecules is therefore another possible mechanism for the development of DN, as it may lead to mesangial congestion and obstruction and thus prevent the removal of molecular debris from the glomerular capillary.
We have studied the development of nephropathy in streptozotocin-diabetic Lewis and DA rats, and found that Lewis rats developed heavier proteinuria and more extensive histological changes than DA rats. This finding provides an animal model in which to test the various hypotheses of DN.
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